Project
Illumina Body Map 2
Navigation
Downloads
Results for PITX3
Z-value: 1.32
Motif logo
Transcription factors associated with PITX3
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
PITX3
|
ENSG00000107859.5 | paired like homeodomain 3 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| PITX3 | hg19_v2_chr10_-_104001231_104001274 | 0.14 | 4.5e-01 | Click! |
Activity profile of PITX3 motif
Sorted Z-values of PITX3 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr12_+_16500037 | 3.28 |
ENST00000536371.1
ENST00000010404.2 |
MGST1
|
microsomal glutathione S-transferase 1 |
| chrX_-_55020511 | 2.52 |
ENST00000375006.3
ENST00000374992.2 |
PFKFB1
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 |
| chr1_+_169079823 | 2.37 |
ENST00000367813.3
|
ATP1B1
|
ATPase, Na+/K+ transporting, beta 1 polypeptide |
| chr18_+_29171689 | 2.15 |
ENST00000237014.3
|
TTR
|
transthyretin |
| chr7_+_73868439 | 2.04 |
ENST00000424337.2
|
GTF2IRD1
|
GTF2I repeat domain containing 1 |
| chr19_-_3479086 | 2.02 |
ENST00000587847.1
|
C19orf77
|
chromosome 19 open reading frame 77 |
| chr16_+_30387141 | 1.78 |
ENST00000566955.1
|
MYLPF
|
myosin light chain, phosphorylatable, fast skeletal muscle |
| chr1_+_145413268 | 1.77 |
ENST00000421822.2
ENST00000336751.5 ENST00000497365.1 ENST00000475797.1 |
HFE2
|
hemochromatosis type 2 (juvenile) |
| chr8_-_42360015 | 1.75 |
ENST00000522707.1
|
SLC20A2
|
solute carrier family 20 (phosphate transporter), member 2 |
| chr12_-_54982420 | 1.56 |
ENST00000257905.8
|
PPP1R1A
|
protein phosphatase 1, regulatory (inhibitor) subunit 1A |
| chr12_+_16500571 | 1.53 |
ENST00000543076.1
ENST00000396210.3 |
MGST1
|
microsomal glutathione S-transferase 1 |
| chr4_+_69962212 | 1.52 |
ENST00000508661.1
|
UGT2B7
|
UDP glucuronosyltransferase 2 family, polypeptide B7 |
| chr3_-_196242233 | 1.51 |
ENST00000397537.2
|
SMCO1
|
single-pass membrane protein with coiled-coil domains 1 |
| chr16_+_30386098 | 1.51 |
ENST00000322861.7
|
MYLPF
|
myosin light chain, phosphorylatable, fast skeletal muscle |
| chr4_+_69962185 | 1.49 |
ENST00000305231.7
|
UGT2B7
|
UDP glucuronosyltransferase 2 family, polypeptide B7 |
| chr7_+_123295861 | 1.46 |
ENST00000458573.2
ENST00000456238.2 |
LMOD2
|
leiomodin 2 (cardiac) |
| chr10_-_74714533 | 1.45 |
ENST00000373032.3
|
PLA2G12B
|
phospholipase A2, group XIIB |
| chr11_+_57310114 | 1.44 |
ENST00000527972.1
ENST00000399154.2 |
SMTNL1
|
smoothelin-like 1 |
| chr5_+_78365577 | 1.38 |
ENST00000518666.1
ENST00000521567.1 |
BHMT2
|
betaine--homocysteine S-methyltransferase 2 |
| chr19_+_45281118 | 1.36 |
ENST00000270279.3
ENST00000341505.4 |
CBLC
|
Cbl proto-oncogene C, E3 ubiquitin protein ligase |
| chr5_-_149669192 | 1.36 |
ENST00000398376.3
|
CAMK2A
|
calcium/calmodulin-dependent protein kinase II alpha |
| chr7_+_73868220 | 1.35 |
ENST00000455841.2
|
GTF2IRD1
|
GTF2I repeat domain containing 1 |
| chr12_+_46777450 | 1.34 |
ENST00000551503.1
|
RP11-96H19.1
|
RP11-96H19.1 |
| chr5_-_39364586 | 1.34 |
ENST00000263408.4
|
C9
|
complement component 9 |
| chr1_+_202385953 | 1.33 |
ENST00000466968.1
|
PPP1R12B
|
protein phosphatase 1, regulatory subunit 12B |
| chr15_+_63050785 | 1.28 |
ENST00000472902.1
|
TLN2
|
talin 2 |
| chrM_-_14670 | 1.26 |
ENST00000361681.2
|
MT-ND6
|
mitochondrially encoded NADH dehydrogenase 6 |
| chr12_-_54982300 | 1.25 |
ENST00000547431.1
|
PPP1R1A
|
protein phosphatase 1, regulatory (inhibitor) subunit 1A |
| chrM_+_5824 | 1.23 |
ENST00000361624.2
|
MT-CO1
|
mitochondrially encoded cytochrome c oxidase I |
| chr7_+_73868120 | 1.22 |
ENST00000265755.3
|
GTF2IRD1
|
GTF2I repeat domain containing 1 |
| chr13_-_28562791 | 1.21 |
ENST00000332715.5
|
URAD
|
ureidoimidazoline (2-oxo-4-hydroxy-4-carboxy-5-) decarboxylase |
| chr3_+_186435137 | 1.20 |
ENST00000447445.1
|
KNG1
|
kininogen 1 |
| chr10_-_76868931 | 1.19 |
ENST00000372700.3
ENST00000473072.2 ENST00000491677.2 ENST00000607131.1 ENST00000372702.3 |
DUSP13
|
dual specificity phosphatase 13 |
| chr1_-_201081579 | 1.17 |
ENST00000367338.3
ENST00000362061.3 |
CACNA1S
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
| chr22_-_36018569 | 1.16 |
ENST00000419229.1
ENST00000406324.1 |
MB
|
myoglobin |
| chr19_-_30199516 | 1.15 |
ENST00000591243.1
|
C19orf12
|
chromosome 19 open reading frame 12 |
| chr4_-_16077741 | 1.15 |
ENST00000447510.2
ENST00000540805.1 ENST00000539194.1 |
PROM1
|
prominin 1 |
| chr3_+_186435065 | 1.13 |
ENST00000287611.2
ENST00000265023.4 |
KNG1
|
kininogen 1 |
| chr11_-_111783595 | 1.12 |
ENST00000528628.1
|
CRYAB
|
crystallin, alpha B |
| chr4_+_169575875 | 1.12 |
ENST00000503457.1
|
PALLD
|
palladin, cytoskeletal associated protein |
| chr14_-_94789663 | 1.12 |
ENST00000557225.1
ENST00000341584.3 |
SERPINA6
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6 |
| chr4_+_41540160 | 1.09 |
ENST00000503057.1
ENST00000511496.1 |
LIMCH1
|
LIM and calponin homology domains 1 |
| chr20_-_62129163 | 1.09 |
ENST00000298049.7
|
EEF1A2
|
eukaryotic translation elongation factor 1 alpha 2 |
| chr17_+_4675175 | 1.08 |
ENST00000270560.3
|
TM4SF5
|
transmembrane 4 L six family member 5 |
| chr3_+_148447887 | 1.08 |
ENST00000475347.1
ENST00000474935.1 ENST00000461609.1 |
AGTR1
|
angiotensin II receptor, type 1 |
| chr12_+_101988627 | 1.08 |
ENST00000547405.1
ENST00000452455.2 ENST00000441232.1 ENST00000360610.2 ENST00000392934.3 ENST00000547509.1 ENST00000361685.2 ENST00000549145.1 ENST00000553190.1 |
MYBPC1
|
myosin binding protein C, slow type |
| chr8_+_134029937 | 1.08 |
ENST00000518108.1
|
TG
|
thyroglobulin |
| chr5_-_38595498 | 1.08 |
ENST00000263409.4
|
LIFR
|
leukemia inhibitory factor receptor alpha |
| chr22_+_31523734 | 1.07 |
ENST00000402238.1
ENST00000404453.1 ENST00000401755.1 |
INPP5J
|
inositol polyphosphate-5-phosphatase J |
| chr10_-_76868866 | 1.05 |
ENST00000607487.1
|
DUSP13
|
dual specificity phosphatase 13 |
| chr6_+_53883790 | 1.05 |
ENST00000509997.1
|
MLIP
|
muscular LMNA-interacting protein |
| chr4_+_70796784 | 1.05 |
ENST00000246891.4
ENST00000444405.3 |
CSN1S1
|
casein alpha s1 |
| chr3_-_124653579 | 1.04 |
ENST00000478191.1
ENST00000311075.3 |
MUC13
|
mucin 13, cell surface associated |
| chr12_+_81101277 | 1.04 |
ENST00000228641.3
|
MYF6
|
myogenic factor 6 (herculin) |
| chr1_+_26758849 | 1.03 |
ENST00000533087.1
ENST00000531312.1 ENST00000525165.1 ENST00000525326.1 ENST00000525546.1 ENST00000436153.2 ENST00000530781.1 |
DHDDS
|
dehydrodolichyl diphosphate synthase |
| chr1_-_165414414 | 1.03 |
ENST00000359842.5
|
RXRG
|
retinoid X receptor, gamma |
| chr4_-_177190364 | 1.02 |
ENST00000296525.3
|
ASB5
|
ankyrin repeat and SOCS box containing 5 |
| chr11_-_111794446 | 1.02 |
ENST00000527950.1
|
CRYAB
|
crystallin, alpha B |
| chr2_+_120770686 | 1.01 |
ENST00000331393.4
ENST00000443124.1 |
EPB41L5
|
erythrocyte membrane protein band 4.1 like 5 |
| chr17_+_68100989 | 1.01 |
ENST00000585558.1
ENST00000392670.1 |
KCNJ16
|
potassium inwardly-rectifying channel, subfamily J, member 16 |
| chr4_-_186877502 | 1.01 |
ENST00000431902.1
ENST00000284776.7 ENST00000415274.1 |
SORBS2
|
sorbin and SH3 domain containing 2 |
| chr11_+_64358110 | 1.00 |
ENST00000377567.2
|
SLC22A12
|
solute carrier family 22 (organic anion/urate transporter), member 12 |
| chr3_+_130650738 | 1.00 |
ENST00000504612.1
|
ATP2C1
|
ATPase, Ca++ transporting, type 2C, member 1 |
| chr12_+_101988774 | 1.00 |
ENST00000545503.2
ENST00000536007.1 ENST00000541119.1 ENST00000361466.2 ENST00000551300.1 ENST00000550270.1 |
MYBPC1
|
myosin binding protein C, slow type |
| chr2_+_234637754 | 1.00 |
ENST00000482026.1
ENST00000609767.1 |
UGT1A3
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A3 UDP glucuronosyltransferase 1 family, polypeptide A8 |
| chr1_+_246887349 | 0.99 |
ENST00000366510.3
|
SCCPDH
|
saccharopine dehydrogenase (putative) |
| chr11_+_18287801 | 0.99 |
ENST00000532858.1
ENST00000405158.2 |
SAA1
|
serum amyloid A1 |
| chr11_+_63449045 | 0.98 |
ENST00000354497.4
|
RTN3
|
reticulon 3 |
| chr3_-_182833863 | 0.98 |
ENST00000492597.1
|
MCCC1
|
methylcrotonoyl-CoA carboxylase 1 (alpha) |
| chr5_+_137203465 | 0.98 |
ENST00000239926.4
|
MYOT
|
myotilin |
| chr11_-_10530723 | 0.98 |
ENST00000536684.1
|
MTRNR2L8
|
MT-RNR2-like 8 |
| chr1_+_31883048 | 0.97 |
ENST00000536859.1
|
SERINC2
|
serine incorporator 2 |
| chr10_+_96443378 | 0.97 |
ENST00000285979.6
|
CYP2C18
|
cytochrome P450, family 2, subfamily C, polypeptide 18 |
| chr11_+_18287721 | 0.96 |
ENST00000356524.4
|
SAA1
|
serum amyloid A1 |
| chrX_+_70435044 | 0.96 |
ENST00000374029.1
ENST00000374022.3 ENST00000447581.1 |
GJB1
|
gap junction protein, beta 1, 32kDa |
| chr5_+_137203557 | 0.96 |
ENST00000515645.1
|
MYOT
|
myotilin |
| chr19_+_35532612 | 0.95 |
ENST00000600390.1
ENST00000597419.1 |
HPN
|
hepsin |
| chr21_-_31864275 | 0.95 |
ENST00000334063.4
|
KRTAP19-3
|
keratin associated protein 19-3 |
| chr1_+_159557607 | 0.95 |
ENST00000255040.2
|
APCS
|
amyloid P component, serum |
| chr15_-_56285742 | 0.93 |
ENST00000435532.3
|
NEDD4
|
neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase |
| chrX_-_15333775 | 0.93 |
ENST00000480796.1
|
ASB11
|
ankyrin repeat and SOCS box containing 11 |
| chr11_-_30608413 | 0.93 |
ENST00000528686.1
|
MPPED2
|
metallophosphoesterase domain containing 2 |
| chr6_+_150690028 | 0.93 |
ENST00000229447.5
ENST00000344419.3 |
IYD
|
iodotyrosine deiodinase |
| chr11_-_111783919 | 0.92 |
ENST00000531198.1
ENST00000533879.1 |
CRYAB
|
crystallin, alpha B |
| chr3_+_148415571 | 0.92 |
ENST00000497524.1
ENST00000349243.3 ENST00000542281.1 ENST00000418473.2 ENST00000404754.2 |
AGTR1
|
angiotensin II receptor, type 1 |
| chr6_+_150690089 | 0.91 |
ENST00000392256.2
|
IYD
|
iodotyrosine deiodinase |
| chr11_-_63376013 | 0.90 |
ENST00000540943.1
|
PLA2G16
|
phospholipase A2, group XVI |
| chr16_-_20566616 | 0.90 |
ENST00000569163.1
|
ACSM2B
|
acyl-CoA synthetase medium-chain family member 2B |
| chr17_-_9694614 | 0.90 |
ENST00000330255.5
ENST00000571134.1 |
DHRS7C
|
dehydrogenase/reductase (SDR family) member 7C |
| chr4_-_17513851 | 0.90 |
ENST00000281243.5
|
QDPR
|
quinoid dihydropteridine reductase |
| chr16_+_28722684 | 0.89 |
ENST00000331666.6
ENST00000395587.1 ENST00000569690.1 ENST00000564243.1 |
EIF3C
|
eukaryotic translation initiation factor 3, subunit C |
| chrM_+_14741 | 0.89 |
ENST00000361789.2
|
MT-CYB
|
mitochondrially encoded cytochrome b |
| chrM_+_12331 | 0.89 |
ENST00000361567.2
|
MT-ND5
|
mitochondrially encoded NADH dehydrogenase 5 |
| chr11_-_111784005 | 0.89 |
ENST00000527899.1
|
CRYAB
|
crystallin, alpha B |
| chrX_-_138304939 | 0.89 |
ENST00000448673.1
|
FGF13
|
fibroblast growth factor 13 |
| chr4_-_186877481 | 0.89 |
ENST00000444781.1
ENST00000432655.1 |
SORBS2
|
sorbin and SH3 domain containing 2 |
| chr13_-_62001982 | 0.88 |
ENST00000409186.1
|
PCDH20
|
protocadherin 20 |
| chr1_-_33336414 | 0.88 |
ENST00000373471.3
ENST00000609187.1 |
FNDC5
|
fibronectin type III domain containing 5 |
| chr10_-_35104185 | 0.87 |
ENST00000374789.3
ENST00000374788.3 ENST00000346874.4 ENST00000374794.3 ENST00000350537.4 ENST00000374790.3 ENST00000374776.1 ENST00000374773.1 ENST00000545693.1 ENST00000545260.1 ENST00000340077.5 |
PARD3
|
par-3 family cell polarity regulator |
| chr2_+_170335924 | 0.87 |
ENST00000554017.1
ENST00000392663.2 ENST00000513963.1 |
BBS5
RP11-724O16.1
|
Bardet-Biedl syndrome 5 Bardet-Biedl syndrome 5 protein; Uncharacterized protein |
| chr6_+_53883708 | 0.87 |
ENST00000514921.1
ENST00000274897.5 ENST00000370877.2 |
MLIP
|
muscular LMNA-interacting protein |
| chr6_+_41021027 | 0.86 |
ENST00000244669.2
|
APOBEC2
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 2 |
| chr12_-_113574028 | 0.85 |
ENST00000546530.1
ENST00000261729.5 |
RASAL1
|
RAS protein activator like 1 (GAP1 like) |
| chr17_+_18625336 | 0.84 |
ENST00000395671.4
ENST00000571542.1 ENST00000395672.2 ENST00000414850.2 ENST00000424146.2 |
TRIM16L
|
tripartite motif containing 16-like |
| chr1_+_43996518 | 0.84 |
ENST00000359947.4
ENST00000438120.1 |
PTPRF
|
protein tyrosine phosphatase, receptor type, F |
| chr16_+_58059470 | 0.84 |
ENST00000219271.3
|
MMP15
|
matrix metallopeptidase 15 (membrane-inserted) |
| chr10_-_54531406 | 0.84 |
ENST00000373968.3
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble |
| chr2_-_152382500 | 0.84 |
ENST00000434685.1
|
NEB
|
nebulin |
| chr10_+_135160844 | 0.84 |
ENST00000423766.1
ENST00000458230.1 |
PRAP1
|
proline-rich acidic protein 1 |
| chr10_-_113943447 | 0.83 |
ENST00000369425.1
ENST00000348367.4 ENST00000423155.1 |
GPAM
|
glycerol-3-phosphate acyltransferase, mitochondrial |
| chr1_-_47407097 | 0.83 |
ENST00000457840.2
|
CYP4A11
|
cytochrome P450, family 4, subfamily A, polypeptide 11 |
| chr11_-_13517565 | 0.83 |
ENST00000282091.1
ENST00000529816.1 |
PTH
|
parathyroid hormone |
| chr5_+_137203541 | 0.83 |
ENST00000421631.2
|
MYOT
|
myotilin |
| chr5_+_140593509 | 0.83 |
ENST00000341948.4
|
PCDHB13
|
protocadherin beta 13 |
| chr16_+_82068830 | 0.83 |
ENST00000199936.4
|
HSD17B2
|
hydroxysteroid (17-beta) dehydrogenase 2 |
| chr2_+_47596287 | 0.83 |
ENST00000263735.4
|
EPCAM
|
epithelial cell adhesion molecule |
| chr3_+_154741907 | 0.82 |
ENST00000492661.1
|
MME
|
membrane metallo-endopeptidase |
| chr12_+_16500599 | 0.82 |
ENST00000535309.1
ENST00000540056.1 ENST00000396209.1 ENST00000540126.1 |
MGST1
|
microsomal glutathione S-transferase 1 |
| chrM_+_9207 | 0.82 |
ENST00000362079.2
|
MT-CO3
|
mitochondrially encoded cytochrome c oxidase III |
| chr17_-_40170506 | 0.82 |
ENST00000589773.1
ENST00000590348.1 |
DNAJC7
|
DnaJ (Hsp40) homolog, subfamily C, member 7 |
| chr9_-_95298927 | 0.82 |
ENST00000395534.2
|
ECM2
|
extracellular matrix protein 2, female organ and adipocyte specific |
| chr11_+_58938903 | 0.81 |
ENST00000532982.1
|
DTX4
|
deltex homolog 4 (Drosophila) |
| chr12_-_103310987 | 0.81 |
ENST00000307000.2
|
PAH
|
phenylalanine hydroxylase |
| chr21_-_43786634 | 0.81 |
ENST00000291527.2
|
TFF1
|
trefoil factor 1 |
| chr19_-_14168391 | 0.81 |
ENST00000589048.1
|
PALM3
|
paralemmin 3 |
| chr19_-_10697895 | 0.81 |
ENST00000591240.1
ENST00000589684.1 ENST00000591676.1 ENST00000250244.6 ENST00000590923.1 |
AP1M2
|
adaptor-related protein complex 1, mu 2 subunit |
| chr19_+_7580103 | 0.81 |
ENST00000596712.1
|
ZNF358
|
zinc finger protein 358 |
| chr11_-_66675371 | 0.81 |
ENST00000393955.2
|
PC
|
pyruvate carboxylase |
| chr6_+_54173227 | 0.81 |
ENST00000259782.4
ENST00000370864.3 |
TINAG
|
tubulointerstitial nephritis antigen |
| chr3_-_149293990 | 0.81 |
ENST00000472417.1
|
WWTR1
|
WW domain containing transcription regulator 1 |
| chr6_+_10585979 | 0.80 |
ENST00000265012.4
|
GCNT2
|
glucosaminyl (N-acetyl) transferase 2, I-branching enzyme (I blood group) |
| chr1_+_59775752 | 0.80 |
ENST00000371212.1
|
FGGY
|
FGGY carbohydrate kinase domain containing |
| chr1_-_31902614 | 0.80 |
ENST00000596131.1
|
AC114494.1
|
HCG1787699; Uncharacterized protein |
| chr14_+_74035763 | 0.79 |
ENST00000238651.5
|
ACOT2
|
acyl-CoA thioesterase 2 |
| chr18_+_8717369 | 0.79 |
ENST00000359865.3
ENST00000400050.3 ENST00000306285.7 |
SOGA2
|
SOGA family member 2 |
| chr7_+_1727755 | 0.79 |
ENST00000424383.2
|
ELFN1
|
extracellular leucine-rich repeat and fibronectin type III domain containing 1 |
| chr2_+_1417228 | 0.79 |
ENST00000382269.3
ENST00000337415.3 ENST00000345913.4 ENST00000346956.3 ENST00000349624.3 ENST00000539820.1 ENST00000329066.4 ENST00000382201.3 |
TPO
|
thyroid peroxidase |
| chr12_-_10978957 | 0.78 |
ENST00000240619.2
|
TAS2R10
|
taste receptor, type 2, member 10 |
| chr17_-_18266797 | 0.77 |
ENST00000316694.3
ENST00000539052.1 |
SHMT1
|
serine hydroxymethyltransferase 1 (soluble) |
| chr19_-_5838768 | 0.77 |
ENST00000527106.1
ENST00000531199.1 ENST00000529165.1 |
FUT6
|
fucosyltransferase 6 (alpha (1,3) fucosyltransferase) |
| chr9_-_93405352 | 0.77 |
ENST00000375765.3
|
DIRAS2
|
DIRAS family, GTP-binding RAS-like 2 |
| chr1_-_231560790 | 0.77 |
ENST00000366641.3
|
EGLN1
|
egl-9 family hypoxia-inducible factor 1 |
| chr13_-_36050819 | 0.77 |
ENST00000379919.4
|
MAB21L1
|
mab-21-like 1 (C. elegans) |
| chr3_-_46608010 | 0.77 |
ENST00000395905.3
|
LRRC2
|
leucine rich repeat containing 2 |
| chr5_+_36606992 | 0.76 |
ENST00000505202.1
|
SLC1A3
|
solute carrier family 1 (glial high affinity glutamate transporter), member 3 |
| chr4_-_186877806 | 0.76 |
ENST00000355634.5
|
SORBS2
|
sorbin and SH3 domain containing 2 |
| chr4_+_155484155 | 0.76 |
ENST00000509493.1
|
FGB
|
fibrinogen beta chain |
| chr3_-_96337000 | 0.76 |
ENST00000600213.2
|
MTRNR2L12
|
MT-RNR2-like 12 (pseudogene) |
| chr16_+_69333585 | 0.76 |
ENST00000570054.2
|
RP11-343C2.11
|
Uncharacterized protein |
| chr4_+_108911036 | 0.76 |
ENST00000505878.1
|
HADH
|
hydroxyacyl-CoA dehydrogenase |
| chr11_+_58695174 | 0.76 |
ENST00000317391.4
|
GLYATL1
|
glycine-N-acyltransferase-like 1 |
| chr18_+_55862622 | 0.75 |
ENST00000456173.2
|
NEDD4L
|
neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase |
| chrM_+_8527 | 0.75 |
ENST00000361899.2
|
MT-ATP6
|
mitochondrially encoded ATP synthase 6 |
| chr14_+_67291158 | 0.75 |
ENST00000555456.1
|
GPHN
|
gephyrin |
| chr11_+_86667117 | 0.74 |
ENST00000531827.1
|
RP11-736K20.6
|
RP11-736K20.6 |
| chr17_-_18266765 | 0.74 |
ENST00000354098.3
|
SHMT1
|
serine hydroxymethyltransferase 1 (soluble) |
| chr4_+_155484103 | 0.74 |
ENST00000302068.4
|
FGB
|
fibrinogen beta chain |
| chr19_-_5838734 | 0.73 |
ENST00000532464.1
ENST00000528505.1 |
FUT6
|
fucosyltransferase 6 (alpha (1,3) fucosyltransferase) |
| chr11_-_116663127 | 0.73 |
ENST00000433069.1
ENST00000542499.1 |
APOA5
|
apolipoprotein A-V |
| chr9_+_131684562 | 0.73 |
ENST00000421063.2
|
PHYHD1
|
phytanoyl-CoA dioxygenase domain containing 1 |
| chr3_-_50340996 | 0.72 |
ENST00000266031.4
ENST00000395143.2 ENST00000457214.2 ENST00000447605.2 ENST00000418723.1 ENST00000395144.2 |
HYAL1
|
hyaluronoglucosaminidase 1 |
| chr4_-_111120132 | 0.72 |
ENST00000506625.1
|
ELOVL6
|
ELOVL fatty acid elongase 6 |
| chr5_-_150467221 | 0.72 |
ENST00000522226.1
|
TNIP1
|
TNFAIP3 interacting protein 1 |
| chr5_+_95066823 | 0.72 |
ENST00000506817.1
ENST00000379982.3 |
RHOBTB3
|
Rho-related BTB domain containing 3 |
| chr15_-_35838348 | 0.71 |
ENST00000561411.1
ENST00000256538.4 ENST00000440392.2 |
DPH6
|
diphthamine biosynthesis 6 |
| chr1_-_165668100 | 0.71 |
ENST00000354775.4
|
ALDH9A1
|
aldehyde dehydrogenase 9 family, member A1 |
| chr1_-_100643765 | 0.71 |
ENST00000370137.1
ENST00000370138.1 ENST00000342895.3 |
LRRC39
|
leucine rich repeat containing 39 |
| chr18_+_44526744 | 0.71 |
ENST00000585469.1
|
KATNAL2
|
katanin p60 subunit A-like 2 |
| chr10_-_5046042 | 0.71 |
ENST00000421196.3
ENST00000455190.1 |
AKR1C2
|
aldo-keto reductase family 1, member C2 |
| chr9_-_112083229 | 0.71 |
ENST00000374566.3
ENST00000374557.4 |
EPB41L4B
|
erythrocyte membrane protein band 4.1 like 4B |
| chr4_-_69536346 | 0.71 |
ENST00000338206.5
|
UGT2B15
|
UDP glucuronosyltransferase 2 family, polypeptide B15 |
| chrX_-_21676442 | 0.71 |
ENST00000379499.2
|
KLHL34
|
kelch-like family member 34 |
| chr2_+_219472637 | 0.71 |
ENST00000417849.1
|
PLCD4
|
phospholipase C, delta 4 |
| chr22_+_38203898 | 0.71 |
ENST00000323205.6
ENST00000248924.6 ENST00000445195.1 |
GCAT
|
glycine C-acetyltransferase |
| chr10_-_116418053 | 0.71 |
ENST00000277895.5
|
ABLIM1
|
actin binding LIM protein 1 |
| chr1_-_201368653 | 0.70 |
ENST00000367313.3
|
LAD1
|
ladinin 1 |
| chr19_+_8483272 | 0.70 |
ENST00000602117.1
|
MARCH2
|
membrane-associated ring finger (C3HC4) 2, E3 ubiquitin protein ligase |
| chr4_-_111120334 | 0.70 |
ENST00000503885.1
|
ELOVL6
|
ELOVL fatty acid elongase 6 |
| chr10_+_104486253 | 0.70 |
ENST00000602868.1
|
SFXN2
|
sideroflexin 2 |
| chr2_-_219154715 | 0.69 |
ENST00000451181.1
ENST00000429501.1 |
TMBIM1
|
transmembrane BAX inhibitor motif containing 1 |
| chr2_+_85661918 | 0.69 |
ENST00000340326.2
|
SH2D6
|
SH2 domain containing 6 |
| chr16_+_72042487 | 0.69 |
ENST00000572887.1
ENST00000219240.4 ENST00000574309.1 ENST00000576145.1 |
DHODH
|
dihydroorotate dehydrogenase (quinone) |
| chr12_+_76653611 | 0.69 |
ENST00000550380.1
|
RP11-54A9.1
|
RP11-54A9.1 |
| chr4_+_108910870 | 0.69 |
ENST00000403312.1
ENST00000603302.1 ENST00000309522.3 |
HADH
|
hydroxyacyl-CoA dehydrogenase |
| chr1_-_201368707 | 0.68 |
ENST00000391967.2
|
LAD1
|
ladinin 1 |
| chr1_-_159684371 | 0.68 |
ENST00000255030.5
ENST00000437342.1 ENST00000368112.1 ENST00000368111.1 ENST00000368110.1 ENST00000343919.2 |
CRP
|
C-reactive protein, pentraxin-related |
| chr8_+_1993152 | 0.68 |
ENST00000262113.4
|
MYOM2
|
myomesin 2 |
| chr1_+_196912902 | 0.67 |
ENST00000476712.2
ENST00000367415.5 |
CFHR2
|
complement factor H-related 2 |
| chrX_-_139866723 | 0.67 |
ENST00000370532.2
|
CDR1
|
cerebellar degeneration-related protein 1, 34kDa |
| chr15_+_44092784 | 0.67 |
ENST00000458412.1
|
HYPK
|
huntingtin interacting protein K |
| chr3_+_154801678 | 0.67 |
ENST00000462837.1
|
MME
|
membrane metallo-endopeptidase |
| chr7_-_74221288 | 0.67 |
ENST00000451013.2
|
GTF2IRD2
|
GTF2I repeat domain containing 2 |
| chr3_-_127455200 | 0.67 |
ENST00000398101.3
|
MGLL
|
monoglyceride lipase |
| chr6_+_160542870 | 0.67 |
ENST00000324965.4
ENST00000457470.2 |
SLC22A1
|
solute carrier family 22 (organic cation transporter), member 1 |
| chr3_-_48647470 | 0.67 |
ENST00000203407.5
|
UQCRC1
|
ubiquinol-cytochrome c reductase core protein I |
| chr7_-_33080506 | 0.67 |
ENST00000381626.2
ENST00000409467.1 ENST00000449201.1 |
NT5C3A
|
5'-nucleotidase, cytosolic IIIA |
| chr6_+_160542821 | 0.67 |
ENST00000366963.4
|
SLC22A1
|
solute carrier family 22 (organic cation transporter), member 1 |
| chr2_+_211342432 | 0.66 |
ENST00000430249.2
|
CPS1
|
carbamoyl-phosphate synthase 1, mitochondrial |
| chr8_+_1993173 | 0.66 |
ENST00000523438.1
|
MYOM2
|
myomesin 2 |
| chr22_-_21581926 | 0.66 |
ENST00000401924.1
|
GGT2
|
gamma-glutamyltransferase 2 |
Network of associatons between targets according to the STRING database.
First level regulatory network of PITX3
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.9 | 5.6 | GO:0071449 | cellular response to lipid hydroperoxide(GO:0071449) |
| 0.9 | 4.6 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
| 0.6 | 1.8 | GO:0052331 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
| 0.5 | 2.0 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
| 0.5 | 1.9 | GO:1904481 | response to tetrahydrofolate(GO:1904481) cellular response to tetrahydrofolate(GO:1904482) |
| 0.5 | 1.9 | GO:0016094 | polyprenol biosynthetic process(GO:0016094) |
| 0.4 | 1.3 | GO:0097254 | renal tubular secretion(GO:0097254) |
| 0.4 | 2.9 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.4 | 0.4 | GO:0072221 | distal convoluted tubule development(GO:0072025) metanephric distal convoluted tubule development(GO:0072221) |
| 0.4 | 1.9 | GO:0007509 | mesoderm migration involved in gastrulation(GO:0007509) |
| 0.4 | 1.5 | GO:0006566 | threonine metabolic process(GO:0006566) |
| 0.3 | 2.4 | GO:1903281 | protein transport into plasma membrane raft(GO:0044861) positive regulation of calcium:sodium antiporter activity(GO:1903281) |
| 0.3 | 1.3 | GO:0051066 | dihydrobiopterin metabolic process(GO:0051066) |
| 0.3 | 1.6 | GO:2000768 | glomerular parietal epithelial cell differentiation(GO:0072139) positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
| 0.3 | 0.6 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
| 0.3 | 1.4 | GO:0007525 | somatic muscle development(GO:0007525) |
| 0.3 | 0.8 | GO:0042700 | luteinizing hormone signaling pathway(GO:0042700) |
| 0.3 | 0.8 | GO:1900158 | negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
| 0.3 | 0.3 | GO:1902956 | negative regulation of nucleoside metabolic process(GO:0045978) negative regulation of oxidative phosphorylation(GO:0090324) negative regulation of cellular respiration(GO:1901856) regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) negative regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902957) negative regulation of ATP metabolic process(GO:1903579) |
| 0.3 | 0.8 | GO:0044205 | 'de novo' UMP biosynthetic process(GO:0044205) |
| 0.3 | 1.0 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.2 | 0.7 | GO:0042040 | molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
| 0.2 | 0.5 | GO:0001978 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
| 0.2 | 1.4 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.2 | 1.0 | GO:0097195 | pilomotor reflex(GO:0097195) |
| 0.2 | 1.4 | GO:1902045 | negative regulation of Fas signaling pathway(GO:1902045) |
| 0.2 | 2.6 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
| 0.2 | 0.9 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
| 0.2 | 0.9 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
| 0.2 | 0.7 | GO:1903718 | carbamoyl phosphate metabolic process(GO:0070408) carbamoyl phosphate biosynthetic process(GO:0070409) response to ammonia(GO:1903717) cellular response to ammonia(GO:1903718) |
| 0.2 | 1.7 | GO:0009753 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
| 0.2 | 2.4 | GO:0071492 | cellular response to UV-A(GO:0071492) |
| 0.2 | 1.3 | GO:0070541 | response to platinum ion(GO:0070541) |
| 0.2 | 0.6 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.2 | 1.1 | GO:0072233 | thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
| 0.2 | 5.3 | GO:0052695 | cellular glucuronidation(GO:0052695) |
| 0.2 | 1.4 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
| 0.2 | 1.0 | GO:0060694 | regulation of cholesterol transporter activity(GO:0060694) |
| 0.2 | 0.8 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.2 | 0.6 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
| 0.2 | 1.0 | GO:0006447 | regulation of translational initiation by iron(GO:0006447) |
| 0.2 | 0.2 | GO:1903625 | negative regulation of DNA catabolic process(GO:1903625) |
| 0.2 | 1.3 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.2 | 1.2 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
| 0.2 | 4.8 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.2 | 1.3 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
| 0.2 | 1.3 | GO:0048241 | epinephrine transport(GO:0048241) |
| 0.2 | 0.6 | GO:0010160 | sensory organ boundary specification(GO:0008052) formation of organ boundary(GO:0010160) taste bud development(GO:0061193) |
| 0.2 | 0.6 | GO:0043438 | acetoacetic acid metabolic process(GO:0043438) |
| 0.2 | 0.9 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.2 | 0.6 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
| 0.2 | 0.9 | GO:0046092 | deoxycytidine metabolic process(GO:0046092) |
| 0.2 | 0.9 | GO:0070124 | mitochondrial translational initiation(GO:0070124) |
| 0.2 | 1.3 | GO:0052199 | negative regulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052199) |
| 0.2 | 0.5 | GO:0070676 | intralumenal vesicle formation(GO:0070676) |
| 0.2 | 0.4 | GO:0019470 | 4-hydroxyproline catabolic process(GO:0019470) |
| 0.2 | 0.5 | GO:0071418 | cellular response to amine stimulus(GO:0071418) |
| 0.2 | 1.3 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.2 | 0.5 | GO:0015993 | molecular hydrogen transport(GO:0015993) |
| 0.2 | 0.5 | GO:1901877 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
| 0.2 | 1.4 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
| 0.2 | 1.2 | GO:0000255 | allantoin metabolic process(GO:0000255) |
| 0.2 | 0.3 | GO:1903719 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 0.2 | 0.5 | GO:2001247 | positive regulation of phosphatidylcholine biosynthetic process(GO:2001247) |
| 0.2 | 1.9 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.2 | 0.3 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
| 0.2 | 0.7 | GO:0033122 | negative regulation of cyclic nucleotide catabolic process(GO:0030806) negative regulation of cAMP catabolic process(GO:0030821) negative regulation of purine nucleotide catabolic process(GO:0033122) |
| 0.2 | 0.8 | GO:0003095 | pressure natriuresis(GO:0003095) |
| 0.2 | 2.4 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
| 0.2 | 1.0 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.2 | 1.0 | GO:0070141 | response to UV-A(GO:0070141) |
| 0.2 | 0.2 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
| 0.2 | 1.1 | GO:0060356 | leucine import(GO:0060356) |
| 0.2 | 0.6 | GO:1901846 | positive regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901846) |
| 0.2 | 0.5 | GO:0001579 | medium-chain fatty acid transport(GO:0001579) |
| 0.2 | 0.5 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
| 0.2 | 0.8 | GO:0030573 | bile acid catabolic process(GO:0030573) |
| 0.2 | 0.9 | GO:0044111 | development involved in symbiotic interaction(GO:0044111) |
| 0.2 | 2.2 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.2 | 0.6 | GO:1903722 | regulation of centriole elongation(GO:1903722) |
| 0.2 | 1.5 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
| 0.2 | 0.6 | GO:0002384 | hepatic immune response(GO:0002384) |
| 0.1 | 1.6 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
| 0.1 | 0.6 | GO:1904049 | negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
| 0.1 | 2.7 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.1 | 0.4 | GO:0007497 | posterior midgut development(GO:0007497) endothelin receptor signaling pathway(GO:0086100) |
| 0.1 | 0.7 | GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling(GO:0010902) |
| 0.1 | 1.2 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
| 0.1 | 2.2 | GO:0019317 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
| 0.1 | 0.7 | GO:0044501 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 0.1 | 0.4 | GO:0070781 | response to biotin(GO:0070781) |
| 0.1 | 0.8 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
| 0.1 | 0.4 | GO:0046022 | positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
| 0.1 | 1.4 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
| 0.1 | 1.5 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
| 0.1 | 0.3 | GO:2000398 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
| 0.1 | 0.4 | GO:0072387 | flavin adenine dinucleotide metabolic process(GO:0072387) |
| 0.1 | 0.4 | GO:0002894 | positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
| 0.1 | 1.0 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
| 0.1 | 0.8 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
| 0.1 | 2.1 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
| 0.1 | 1.9 | GO:0030497 | fatty acid elongation(GO:0030497) |
| 0.1 | 0.1 | GO:2000584 | regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000583) negative regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000584) |
| 0.1 | 2.0 | GO:0055095 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
| 0.1 | 0.7 | GO:0043686 | co-translational protein modification(GO:0043686) |
| 0.1 | 0.4 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
| 0.1 | 0.5 | GO:0018352 | protein-pyridoxal-5-phosphate linkage(GO:0018352) |
| 0.1 | 1.3 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
| 0.1 | 0.1 | GO:0048268 | clathrin coat assembly(GO:0048268) |
| 0.1 | 0.5 | GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
| 0.1 | 0.4 | GO:0072684 | mitochondrial tRNA 3'-trailer cleavage, endonucleolytic(GO:0072684) |
| 0.1 | 0.4 | GO:0050955 | thermoception(GO:0050955) |
| 0.1 | 0.9 | GO:0021784 | postganglionic parasympathetic fiber development(GO:0021784) |
| 0.1 | 0.5 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
| 0.1 | 3.3 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.1 | 0.4 | GO:0060129 | regulation of calcium-independent cell-cell adhesion(GO:0051040) thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
| 0.1 | 0.2 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
| 0.1 | 1.6 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.1 | 0.8 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.1 | 1.5 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
| 0.1 | 0.4 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
| 0.1 | 0.4 | GO:0071314 | cellular response to cocaine(GO:0071314) |
| 0.1 | 0.8 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.1 | 0.4 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
| 0.1 | 0.3 | GO:1904251 | regulation of bile acid metabolic process(GO:1904251) |
| 0.1 | 0.6 | GO:1901091 | regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
| 0.1 | 1.3 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.1 | 0.5 | GO:0019521 | aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
| 0.1 | 0.3 | GO:0032707 | negative regulation of interleukin-23 production(GO:0032707) |
| 0.1 | 0.7 | GO:0036111 | very long-chain fatty-acyl-CoA metabolic process(GO:0036111) |
| 0.1 | 0.3 | GO:0009441 | glycolate metabolic process(GO:0009441) |
| 0.1 | 1.2 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
| 0.1 | 2.7 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
| 0.1 | 0.4 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
| 0.1 | 1.0 | GO:0006558 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
| 0.1 | 0.3 | GO:0003147 | neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) |
| 0.1 | 0.4 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
| 0.1 | 0.4 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
| 0.1 | 0.3 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
| 0.1 | 0.9 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
| 0.1 | 0.4 | GO:0006850 | mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
| 0.1 | 1.4 | GO:0071265 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
| 0.1 | 0.6 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
| 0.1 | 0.4 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
| 0.1 | 0.3 | GO:0051780 | mevalonate transport(GO:0015728) behavioral response to nutrient(GO:0051780) |
| 0.1 | 0.2 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.1 | 0.4 | GO:0044537 | regulation of circulating fibrinogen levels(GO:0044537) |
| 0.1 | 0.8 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.1 | 2.3 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.1 | 4.3 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
| 0.1 | 0.3 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.1 | 1.0 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
| 0.1 | 0.4 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
| 0.1 | 0.6 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
| 0.1 | 1.3 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
| 0.1 | 1.4 | GO:0015747 | urate transport(GO:0015747) |
| 0.1 | 1.0 | GO:0006552 | leucine catabolic process(GO:0006552) |
| 0.1 | 3.8 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
| 0.1 | 1.7 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
| 0.1 | 1.5 | GO:0072257 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
| 0.1 | 0.8 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
| 0.1 | 0.2 | GO:0052314 | phytoalexin metabolic process(GO:0052314) |
| 0.1 | 0.8 | GO:0050893 | sensory processing(GO:0050893) |
| 0.1 | 0.8 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
| 0.1 | 0.7 | GO:0071926 | endocannabinoid signaling pathway(GO:0071926) regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.1 | 2.2 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 0.1 | 0.2 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
| 0.1 | 0.1 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
| 0.1 | 4.6 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.1 | 0.6 | GO:1900827 | positive regulation of cell communication by electrical coupling(GO:0010650) maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.1 | 0.4 | GO:0009635 | response to herbicide(GO:0009635) |
| 0.1 | 0.5 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.1 | 0.2 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.1 | 1.2 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
| 0.1 | 0.8 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
| 0.1 | 0.2 | GO:0002155 | thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
| 0.1 | 0.3 | GO:0051389 | inactivation of MAPKK activity(GO:0051389) |
| 0.1 | 0.5 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
| 0.1 | 0.3 | GO:2000395 | regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
| 0.1 | 0.7 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
| 0.1 | 1.2 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.1 | 2.3 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
| 0.1 | 1.0 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
| 0.1 | 0.5 | GO:0030035 | microspike assembly(GO:0030035) |
| 0.1 | 1.0 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
| 0.1 | 1.1 | GO:0006824 | cobalt ion transport(GO:0006824) |
| 0.1 | 0.2 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
| 0.1 | 0.3 | GO:1904106 | protein localization to microvillus(GO:1904106) |
| 0.1 | 0.4 | GO:1904579 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
| 0.1 | 0.3 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
| 0.1 | 0.2 | GO:0046709 | IDP metabolic process(GO:0046707) IDP catabolic process(GO:0046709) |
| 0.1 | 0.2 | GO:1904815 | negative regulation of protein localization to chromosome, telomeric region(GO:1904815) |
| 0.1 | 0.2 | GO:1900365 | positive regulation of mRNA polyadenylation(GO:1900365) |
| 0.1 | 3.5 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.1 | 0.7 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
| 0.1 | 8.0 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.1 | 0.4 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
| 0.1 | 0.2 | GO:0046356 | acetyl-CoA catabolic process(GO:0046356) |
| 0.1 | 0.7 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.1 | 1.4 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
| 0.1 | 1.9 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.1 | 0.2 | GO:0006423 | cysteinyl-tRNA aminoacylation(GO:0006423) |
| 0.1 | 0.2 | GO:0006425 | glutaminyl-tRNA aminoacylation(GO:0006425) |
| 0.1 | 0.2 | GO:0032581 | ER-dependent peroxisome organization(GO:0032581) |
| 0.1 | 0.5 | GO:0051563 | smooth endoplasmic reticulum calcium ion homeostasis(GO:0051563) |
| 0.1 | 0.7 | GO:0051549 | positive regulation of keratinocyte migration(GO:0051549) |
| 0.1 | 0.4 | GO:1901162 | primary amino compound biosynthetic process(GO:1901162) |
| 0.1 | 0.5 | GO:0008218 | bioluminescence(GO:0008218) |
| 0.1 | 0.8 | GO:0032888 | regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
| 0.1 | 0.4 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
| 0.1 | 0.2 | GO:0031247 | actin rod assembly(GO:0031247) |
| 0.1 | 0.6 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
| 0.1 | 1.7 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
| 0.1 | 0.4 | GO:0019242 | methylglyoxal biosynthetic process(GO:0019242) |
| 0.1 | 0.2 | GO:1904875 | regulation of DNA ligase activity(GO:1904875) |
| 0.1 | 0.8 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
| 0.1 | 0.4 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
| 0.1 | 0.5 | GO:0061760 | antifungal innate immune response(GO:0061760) |
| 0.1 | 0.3 | GO:0048698 | negative regulation of collateral sprouting in absence of injury(GO:0048698) |
| 0.1 | 0.5 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
| 0.1 | 0.2 | GO:0006710 | androgen catabolic process(GO:0006710) |
| 0.1 | 0.8 | GO:0070836 | caveola assembly(GO:0070836) |
| 0.1 | 0.7 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) |
| 0.1 | 0.4 | GO:0097052 | L-kynurenine metabolic process(GO:0097052) |
| 0.1 | 0.3 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
| 0.1 | 0.3 | GO:0099545 | cytoskeletal matrix organization at active zone(GO:0048789) neurexin clustering involved in presynaptic membrane assembly(GO:0097115) retrograde trans-synaptic signaling by trans-synaptic protein complex(GO:0098942) trans-synaptic signaling by trans-synaptic complex(GO:0099545) |
| 0.1 | 0.1 | GO:1903047 | mitotic cell cycle process(GO:1903047) |
| 0.1 | 0.2 | GO:0014839 | myoblast migration involved in skeletal muscle regeneration(GO:0014839) |
| 0.1 | 0.2 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
| 0.1 | 0.2 | GO:1902568 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
| 0.1 | 0.2 | GO:0032242 | regulation of nucleoside transport(GO:0032242) positive regulation of necroptotic process(GO:0060545) |
| 0.1 | 0.3 | GO:2000619 | negative regulation of histone H3-K9 dimethylation(GO:1900110) regulation of TORC2 signaling(GO:1903939) negative regulation of histone H4-K16 acetylation(GO:2000619) |
| 0.1 | 0.3 | GO:0050883 | musculoskeletal movement, spinal reflex action(GO:0050883) |
| 0.1 | 0.4 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
| 0.1 | 0.3 | GO:0001971 | negative regulation of activation of membrane attack complex(GO:0001971) |
| 0.1 | 1.4 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
| 0.1 | 0.6 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
| 0.1 | 0.6 | GO:0015825 | L-serine transport(GO:0015825) |
| 0.1 | 0.6 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
| 0.1 | 0.3 | GO:0036324 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
| 0.1 | 0.5 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.1 | 0.4 | GO:0034959 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.1 | 1.6 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.1 | 0.5 | GO:0006600 | creatine metabolic process(GO:0006600) |
| 0.1 | 0.7 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
| 0.1 | 0.3 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.1 | 1.1 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.1 | 0.3 | GO:0070171 | negative regulation of tooth mineralization(GO:0070171) |
| 0.1 | 0.3 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
| 0.1 | 0.9 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
| 0.1 | 1.2 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.1 | 0.9 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
| 0.1 | 0.7 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.1 | 0.2 | GO:0006433 | glutamyl-tRNA aminoacylation(GO:0006424) prolyl-tRNA aminoacylation(GO:0006433) |
| 0.1 | 0.1 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
| 0.1 | 0.7 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.1 | 0.8 | GO:1904871 | regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) |
| 0.1 | 1.5 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
| 0.1 | 0.2 | GO:0046603 | negative regulation of mitotic centrosome separation(GO:0046603) |
| 0.1 | 1.1 | GO:0060155 | platelet dense granule organization(GO:0060155) |
| 0.1 | 0.3 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
| 0.1 | 0.7 | GO:0071313 | cellular response to caffeine(GO:0071313) |
| 0.1 | 0.9 | GO:0006413 | translational initiation(GO:0006413) |
| 0.1 | 0.3 | GO:0098582 | innate vocalization behavior(GO:0098582) |
| 0.1 | 0.3 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
| 0.1 | 4.1 | GO:0006953 | acute-phase response(GO:0006953) |
| 0.1 | 0.1 | GO:0018307 | enzyme active site formation(GO:0018307) |
| 0.1 | 0.3 | GO:0048749 | compound eye development(GO:0048749) |
| 0.1 | 0.6 | GO:0015808 | L-alanine transport(GO:0015808) |
| 0.1 | 1.0 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.1 | 0.2 | GO:0035570 | N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
| 0.1 | 0.4 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
| 0.1 | 0.2 | GO:1990502 | dense core granule maturation(GO:1990502) |
| 0.1 | 1.1 | GO:1901750 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 0.1 | 0.4 | GO:0093001 | glycolysis from storage polysaccharide through glucose-1-phosphate(GO:0093001) |
| 0.1 | 0.2 | GO:0033341 | regulation of collagen binding(GO:0033341) |
| 0.1 | 1.0 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.1 | 1.7 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.1 | 1.6 | GO:0003334 | keratinocyte development(GO:0003334) |
| 0.1 | 0.3 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
| 0.1 | 0.7 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.1 | 0.3 | GO:0009304 | tRNA transcription(GO:0009304) |
| 0.1 | 0.6 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 0.1 | 0.6 | GO:0046085 | adenosine metabolic process(GO:0046085) |
| 0.1 | 0.1 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
| 0.1 | 0.2 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
| 0.1 | 0.3 | GO:2001151 | regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
| 0.1 | 0.8 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
| 0.1 | 1.2 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
| 0.1 | 0.3 | GO:1904685 | positive regulation of metalloendopeptidase activity(GO:1904685) |
| 0.1 | 1.2 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 0.1 | 0.1 | GO:1901253 | regulation of intracellular transport of viral material(GO:1901252) negative regulation of intracellular transport of viral material(GO:1901253) |
| 0.1 | 0.3 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
| 0.1 | 0.7 | GO:2000680 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
| 0.1 | 0.4 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
| 0.1 | 0.4 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
| 0.1 | 0.3 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
| 0.1 | 0.7 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
| 0.1 | 0.2 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) |
| 0.1 | 0.8 | GO:0060056 | mammary gland involution(GO:0060056) |
| 0.1 | 0.3 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
| 0.1 | 0.5 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
| 0.1 | 0.2 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
| 0.1 | 0.2 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
| 0.1 | 0.4 | GO:1902847 | regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
| 0.1 | 1.4 | GO:0051639 | actin filament network formation(GO:0051639) |
| 0.1 | 0.6 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.1 | 0.1 | GO:0070168 | negative regulation of bone mineralization(GO:0030502) negative regulation of biomineral tissue development(GO:0070168) |
| 0.1 | 2.0 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
| 0.1 | 0.4 | GO:0032439 | endosome localization(GO:0032439) |
| 0.1 | 0.2 | GO:1902362 | melanocyte apoptotic process(GO:1902362) |
| 0.1 | 0.4 | GO:0006974 | cellular response to DNA damage stimulus(GO:0006974) |
| 0.1 | 0.2 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.1 | 0.3 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
| 0.1 | 0.9 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) |
| 0.1 | 0.3 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.1 | 0.9 | GO:0043248 | proteasome assembly(GO:0043248) |
| 0.1 | 0.6 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
| 0.1 | 0.4 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
| 0.1 | 0.9 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
| 0.0 | 0.5 | GO:0006004 | fucose metabolic process(GO:0006004) |
| 0.0 | 0.2 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
| 0.0 | 0.3 | GO:0006574 | valine catabolic process(GO:0006574) |
| 0.0 | 0.2 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
| 0.0 | 0.2 | GO:0098907 | protein localization to T-tubule(GO:0036371) regulation of SA node cell action potential(GO:0098907) |
| 0.0 | 0.5 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
| 0.0 | 0.7 | GO:1901017 | negative regulation of potassium ion transmembrane transporter activity(GO:1901017) negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
| 0.0 | 0.3 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 0.0 | 0.1 | GO:2000276 | negative regulation of oxidative phosphorylation uncoupler activity(GO:2000276) |
| 0.0 | 0.3 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.0 | 0.2 | GO:0071393 | cellular response to progesterone stimulus(GO:0071393) |
| 0.0 | 0.6 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
| 0.0 | 1.1 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
| 0.0 | 1.1 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.0 | 0.2 | GO:0046502 | uroporphyrinogen III biosynthetic process(GO:0006780) uroporphyrinogen III metabolic process(GO:0046502) |
| 0.0 | 0.2 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.0 | 3.2 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
| 0.0 | 0.1 | GO:0042245 | RNA repair(GO:0042245) white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
| 0.0 | 0.2 | GO:0035105 | sterol regulatory element binding protein import into nucleus(GO:0035105) |
| 0.0 | 0.2 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
| 0.0 | 0.3 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
| 0.0 | 0.2 | GO:0015862 | uridine transport(GO:0015862) |
| 0.0 | 0.1 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
| 0.0 | 0.4 | GO:0006013 | mannose metabolic process(GO:0006013) |
| 0.0 | 0.2 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
| 0.0 | 0.2 | GO:0034334 | adherens junction maintenance(GO:0034334) |
| 0.0 | 0.4 | GO:0006068 | ethanol catabolic process(GO:0006068) |
| 0.0 | 0.4 | GO:1901189 | positive regulation of ephrin receptor signaling pathway(GO:1901189) positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901297) positive regulation of canonical Wnt signaling pathway involved in heart development(GO:1905068) |
| 0.0 | 0.2 | GO:0000103 | sulfate assimilation(GO:0000103) |
| 0.0 | 0.8 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.0 | 0.2 | GO:0032099 | negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
| 0.0 | 0.3 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
| 0.0 | 1.0 | GO:0019321 | pentose metabolic process(GO:0019321) |
| 0.0 | 0.3 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.0 | 0.2 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
| 0.0 | 0.3 | GO:0000101 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
| 0.0 | 0.9 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
| 0.0 | 0.2 | GO:0097190 | apoptotic signaling pathway(GO:0097190) |
| 0.0 | 2.3 | GO:1901016 | regulation of potassium ion transmembrane transporter activity(GO:1901016) |
| 0.0 | 0.6 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
| 0.0 | 0.3 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
| 0.0 | 0.8 | GO:0043476 | pigment accumulation(GO:0043476) cellular pigment accumulation(GO:0043482) |
| 0.0 | 2.0 | GO:0010107 | potassium ion import(GO:0010107) |
| 0.0 | 0.0 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.0 | 1.1 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
| 0.0 | 0.1 | GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
| 0.0 | 0.5 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.0 | 0.3 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
| 0.0 | 1.0 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.0 | 0.1 | GO:0001575 | globoside metabolic process(GO:0001575) |
| 0.0 | 0.2 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.0 | 0.1 | GO:1903598 | positive regulation of gap junction assembly(GO:1903598) |
| 0.0 | 0.4 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
| 0.0 | 0.1 | GO:0036269 | swimming behavior(GO:0036269) |
| 0.0 | 0.2 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
| 0.0 | 0.2 | GO:0035803 | egg coat formation(GO:0035803) |
| 0.0 | 0.2 | GO:0061740 | protein targeting to lysosome involved in chaperone-mediated autophagy(GO:0061740) |
| 0.0 | 0.1 | GO:0051102 | DNA ligation involved in DNA recombination(GO:0051102) |
| 0.0 | 0.5 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 0.0 | 0.2 | GO:0071504 | cellular response to heparin(GO:0071504) |
| 0.0 | 0.7 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
| 0.0 | 4.6 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
| 0.0 | 0.2 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.0 | 0.3 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
| 0.0 | 1.2 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
| 0.0 | 0.3 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.0 | 0.2 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 0.0 | 1.2 | GO:0090662 | ATP hydrolysis coupled transmembrane transport(GO:0090662) |
| 0.0 | 0.4 | GO:0042737 | drug catabolic process(GO:0042737) |
| 0.0 | 0.6 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
| 0.0 | 0.3 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
| 0.0 | 0.3 | GO:0072734 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.0 | 0.2 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
| 0.0 | 0.1 | GO:0097068 | response to thyroxine(GO:0097068) response to L-phenylalanine derivative(GO:1904386) |
| 0.0 | 0.5 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
| 0.0 | 4.1 | GO:0005977 | glycogen metabolic process(GO:0005977) |
| 0.0 | 0.3 | GO:0070475 | rRNA base methylation(GO:0070475) |
| 0.0 | 0.3 | GO:0008063 | Toll signaling pathway(GO:0008063) |
| 0.0 | 0.1 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
| 0.0 | 0.7 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
| 0.0 | 0.2 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
| 0.0 | 0.2 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
| 0.0 | 0.3 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
| 0.0 | 0.7 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 0.0 | 0.1 | GO:0010513 | positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
| 0.0 | 0.2 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
| 0.0 | 0.1 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
| 0.0 | 0.2 | GO:0043489 | RNA stabilization(GO:0043489) |
| 0.0 | 0.3 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
| 0.0 | 0.3 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 0.0 | 0.7 | GO:0051923 | sulfation(GO:0051923) |
| 0.0 | 0.2 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
| 0.0 | 0.2 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
| 0.0 | 0.2 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
| 0.0 | 0.5 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
| 0.0 | 0.2 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) |
| 0.0 | 0.3 | GO:0045598 | regulation of fat cell differentiation(GO:0045598) |
| 0.0 | 0.7 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) |
| 0.0 | 2.2 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
| 0.0 | 0.1 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
| 0.0 | 0.4 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
| 0.0 | 1.1 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
| 0.0 | 0.8 | GO:1901685 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 0.0 | 0.2 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
| 0.0 | 0.5 | GO:0015886 | heme transport(GO:0015886) |
| 0.0 | 0.1 | GO:0048075 | positive regulation of eye pigmentation(GO:0048075) |
| 0.0 | 1.1 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.0 | 0.6</ |